3 patent expirations in 2024 and how companies are pivoting

With the patent for Xarelto, a blockbuster blood thinner, expiring, Bayer and Johnson & Johnson are working to protect their leading drug product. This battle has reached the courts with two pharma giants taking on companies attempting to bring generic competition to market.